• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗神经疾病的新途径:头孢曲松,一种具有行为神经元作用的老抗生素。

A new avenue for treating neuronal diseases: Ceftriaxone, an old antibiotic demonstrating behavioral neuronal effects.

机构信息

Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, 10002, Taiwan, ROC.

Department of Experimental and Clinical Medicine, Section of Neuroscience and Cell Biology, Universita Politecnica delle Marche, Ancona, Italy.

出版信息

Behav Brain Res. 2019 May 17;364:149-156. doi: 10.1016/j.bbr.2019.02.020. Epub 2019 Feb 12.

DOI:10.1016/j.bbr.2019.02.020
PMID:30768995
Abstract

Several neurodegenerative disorders, namely Parkinson's disease dementia, dementia with Lewy bodies, and Alzheimer's disease, share common pathophysiological features, such as (1) cognitive deficits, (2) glutamatergic hyperactivity-related excitotoxicity, and (3) deposition of α-synuclein (α-syn) and β-amyloid (Aβ). Ceftriaxone (CEF) is a well-tested and safe drug that has been used as an antibiotic for several decades. Recent studies have demonstrated the following effects of CEF: (1) increasing glutamate transporter-1 expression and glutamate reuptake and suppressing excitotoxicity, (2) binding well with α-syn and inhibition of α-syn polymerization, (3) modulating expression of genes related to Aβ metabolism, and (4) enhancing neurogenesis and recovery of neuronal density. In addition, our data revealed that CEF ameliorates seizure and abnormal neuronal firing in the brain. These results suggest the potential of CEF in treating neuronal disorders. This paper addresses the effects and pharmacology of CEF.

摘要

几种神经退行性疾病,如帕金森病痴呆、路易体痴呆和阿尔茨海默病,具有共同的病理生理特征,如(1)认知缺陷,(2)谷氨酸能过度活跃相关的兴奋性毒性,和(3)α-突触核蛋白(α-syn)和β-淀粉样蛋白(Aβ)的沉积。头孢曲松(CEF)是一种经过充分测试和安全的药物,已被用作抗生素数十年。最近的研究表明 CEF 具有以下作用:(1)增加谷氨酸转运体-1 的表达和谷氨酸再摄取,抑制兴奋性毒性,(2)与 α-syn 结合良好并抑制 α-syn 聚合,(3)调节与 Aβ代谢相关的基因表达,和(4)增强神经发生和神经元密度的恢复。此外,我们的数据显示 CEF 可改善大脑中的癫痫发作和异常神经元放电。这些结果表明 CEF 在治疗神经元疾病方面具有潜力。本文探讨了 CEF 的作用和药理学。

相似文献

1
A new avenue for treating neuronal diseases: Ceftriaxone, an old antibiotic demonstrating behavioral neuronal effects.治疗神经疾病的新途径:头孢曲松,一种具有行为神经元作用的老抗生素。
Behav Brain Res. 2019 May 17;364:149-156. doi: 10.1016/j.bbr.2019.02.020. Epub 2019 Feb 12.
2
Ceftriaxone Treatment for Neuronal Deficits: A Histological and MEMRI Study in a Rat Model of Dementia with Lewy Bodies.头孢曲松治疗神经元缺陷:在路易体痴呆大鼠模型中的组织学和磁共振弹性成像研究
Behav Neurol. 2018 Aug 1;2018:4618716. doi: 10.1155/2018/4618716. eCollection 2018.
3
Ceftriaxone reverses deficits of behavior and neurogenesis in an MPTP-induced rat model of Parkinson's disease dementia.头孢曲松可逆转MPTP诱导的帕金森病痴呆大鼠模型中的行为缺陷和神经发生障碍。
Brain Res Bull. 2017 Jun;132:129-138. doi: 10.1016/j.brainresbull.2017.05.015. Epub 2017 May 30.
4
Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson's disease rat model: An immunohistochemical and MRI study.头孢曲松可预防帕金森病大鼠模型中出现的神经退行性变和神经发生减少:一项免疫组织化学和MRI研究。
Behav Brain Res. 2016 May 15;305:126-39. doi: 10.1016/j.bbr.2016.02.034. Epub 2016 Mar 3.
5
Use of Ceftriaxone in Treating Cognitive and Neuronal Deficits Associated With Dementia With Lewy Bodies.头孢曲松在治疗与路易体痴呆相关的认知和神经元缺陷中的应用。
Front Neurosci. 2019 May 24;13:507. doi: 10.3389/fnins.2019.00507. eCollection 2019.
6
Synergistic effects of ceftriaxone and erythropoietin on neuronal and behavioral deficits in an MPTP-induced animal model of Parkinson's disease dementia.头孢曲松和促红细胞生成素对MPTP诱导的帕金森病痴呆动物模型中神经元和行为缺陷的协同作用。
Behav Brain Res. 2015 Nov 1;294:198-207. doi: 10.1016/j.bbr.2015.08.011. Epub 2015 Aug 18.
7
Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties.头孢曲松通过调节脑内淀粉样β代谢相关基因表达发挥神经保护作用的新机制。
BMC Neurosci. 2018 Apr 19;19(Suppl 1):13. doi: 10.1186/s12868-018-0412-5.
8
Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence.头孢曲松治疗对加速衰老大鼠模型认知和神经元缺陷的神经保护作用。
Behav Brain Res. 2017 Jul 14;330:8-16. doi: 10.1016/j.bbr.2017.05.002. Epub 2017 May 6.
9
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.植物环烯醚萜类化合物在阿尔茨海默病和帕金森病中的治疗潜力:综述。
Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8.
10
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.帕金森病患者脑脊液中α-突触核蛋白和tau 浓度:一项队列研究。
Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X.

引用本文的文献

1
Ceftriaxone Inhibits Conditioned Fear and Compulsive-like Repetitive Marble Digging without Central Nervous System Side Effects Typical of Diazepam-A Study on DBA2/J Mice and a High-5HT Subline of Wistar-Zagreb 5HT Rats.头孢曲松可抑制条件性恐惧和强迫样重复挖掘弹珠行为,且无地西泮典型的中枢神经系统副作用——对DBA2/J小鼠和Wistar-Zagreb 5HT大鼠的高5-羟色胺亚系的研究
Biomedicines. 2024 Aug 1;12(8):1711. doi: 10.3390/biomedicines12081711.
2
Cognitive Impairment in Parkinson's Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches.帕金森病认知障碍:关注新兴药物治疗方法的最新概述。
Medicina (Kaunas). 2023 Oct 1;59(10):1756. doi: 10.3390/medicina59101756.
3
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome.
神经退行性和神经发育性疾病与肠脑轴:靶向微生物组的治疗潜力。
Int J Mol Sci. 2023 May 31;24(11):9577. doi: 10.3390/ijms24119577.
4
Restoring calcium homeostasis in Purkinje cells arrests neurodegeneration and neuroinflammation in the ARSACS mouse model.恢复浦肯野细胞内钙稳态可阻止 ARSACS 小鼠模型的神经退行性变和神经炎症。
JCI Insight. 2023 Jun 22;8(12):e163576. doi: 10.1172/jci.insight.163576.
5
Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease.散发性帕金森病发病机制中的分子和细胞相互作用。
Int J Mol Sci. 2022 Oct 27;23(21):13043. doi: 10.3390/ijms232113043.
6
The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.肠道微生物群与帕金森病的相互作用:对诊断和治疗的影响。
Int J Mol Sci. 2022 Oct 14;23(20):12289. doi: 10.3390/ijms232012289.
7
Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson's disease.针对帕金森病中 alpha-synuclein 的诊断和治疗药物。
J Neurol. 2022 Nov;269(11):5762-5786. doi: 10.1007/s00415-022-11267-9. Epub 2022 Jul 13.
8
Ceftriaxone to PRevent pneumOnia and inflammaTion aftEr Cardiac arresT (PROTECT): study protocol for a randomized, placebo-controlled trial.头孢曲松预防心脏骤停后肺炎和炎症(PROTECT):一项随机、安慰剂对照试验的研究方案。
Trials. 2022 Mar 4;23(1):197. doi: 10.1186/s13063-022-06127-w.
9
The Role of Pathogens and Anti-Infective Agents in Parkinson's Disease, from Etiology to Therapeutic Implications.病原体和抗感染药物在帕金森病中的作用:从病因学到治疗意义。
J Parkinsons Dis. 2022;12(1):27-44. doi: 10.3233/JPD-212929.
10
Neuroprotective Effects of Ceftriaxone Involve the Reduction of Aβ Burden and Neuroinflammatory Response in a Mouse Model of Alzheimer's Disease.头孢曲松的神经保护作用涉及在阿尔茨海默病小鼠模型中减轻Aβ负担和神经炎症反应。
Front Neurosci. 2021 Sep 29;15:736786. doi: 10.3389/fnins.2021.736786. eCollection 2021.